FDA — authorised 12 May 2023
- Marketing authorisation holder: ASTELLAS
- Status: approved
🇺🇸 Veozah in United States
FDA authorised Veozah on 12 May 2023
Marketing authorisations
FDA — authorised 12 May 2023
- Application: NDA216578
- Marketing authorisation holder: ASTELLAS
- Local brand name: VEOZAH
- Indication: TABLET — ORAL
- Status: approved
Veozah in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Veozah approved in United States?
Yes. FDA authorised it on 12 May 2023; FDA authorised it on 12 May 2023.
Who is the marketing authorisation holder for Veozah in United States?
ASTELLAS holds the US marketing authorisation.